http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2015DN04089-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd042bcccbc1daa26d3556ba65b6c67e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9859604697ee69d2b82c6b7e73274bc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580ee461628732a43d6023e53b665cfa
publicationDate 2015-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IN-2015DN04089-A
abstract The present invention relates to compounds of formula I: for use in treating pulmonary arterial hypertension and associated conditions where R1 R2 and R3 are the same or different and signify hydrogens halogens alkyl alkylaryl alkyloxy hydroxy nitro amino alkylcarbonylamino alkylamino or dialkylamino group; R4 signifies hydrogen alkyl alkylaryl or alkylheteroaryl; X signifies CH2 oxygen atom or sulphur atom; n is 1 2 or 3 with the proviso that when n is 1 X is not CH2; and the individual (R) and (S) enantiomers or mixtures of enantiomers and pharmaceutically acceptable salts thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021005623-A1
priorityDate 2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526

Total number of triples: 29.